Mutated hpv-16 e7 polypeptide, pharmaceutical composition...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/62 (2006.01) A61K 39/12 (2006.01) A61P 35/00 (2006.01) C07K 14/025 (2006.01) C07K 14/155 (2006.01) C07K 14/16 (2006.01) C07K 16/08 (2006.01) C07K 19/00 (2006.01) C12N 15/37 (2006.01) C12N 15/48 (2006.01) C12P 21/02 (2006.01)

Patent

CA 2483468

The present invention is related to a mutated E7 polypeptide obtained from the human Papillomavirus HPV-16 as well as the pharmaceutical composition comprising it and its preparation process.

L'invention porte sur un polypeptide HPV-16 e7 muté obtenu à partir du Papillomavirus HPV-16, sur des préparations pharmaceutiques le contenant, et sur son procédé de préparation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mutated hpv-16 e7 polypeptide, pharmaceutical composition... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mutated hpv-16 e7 polypeptide, pharmaceutical composition..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutated hpv-16 e7 polypeptide, pharmaceutical composition... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1910129

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.